Development
Xylem Inc.
XYL
$142.65
-$0.83-0.58%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 7.36B | 6.75B | 6.06B | 5.70B | 5.52B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.36B | 6.75B | 6.06B | 5.70B | 5.52B |
| Cost of Revenue | 4.65B | 4.22B | 3.76B | 3.54B | 3.44B |
| Gross Profit | 2.72B | 2.53B | 2.29B | 2.16B | 2.08B |
| SG&A Expenses | 1.63B | 1.55B | 1.35B | 1.26B | 1.24B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.51B | 5.99B | 5.33B | 5.00B | 4.88B |
| Operating Income | 859.00M | 763.00M | 731.00M | 695.00M | 641.00M |
| Income Before Tax | 635.00M | 614.00M | 446.00M | 468.00M | 440.00M |
| Income Tax Expenses | 26.00M | 122.00M | 94.00M | 96.00M | 85.00M |
| Earnings from Continuing Operations | 609.00 | 492.00 | 352.00 | 372.00 | 355.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 609.00M | 492.00M | 352.00M | 372.00M | 355.00M |
| EBIT | 859.00M | 763.00M | 731.00M | 695.00M | 641.00M |
| EBITDA | 1.30B | 1.13B | 1.00B | 936.00M | 880.00M |
| EPS Basic | 2.73 | 2.45 | 1.88 | 2.06 | 1.97 |
| Normalized Basic EPS | 2.41 | 2.31 | 2.37 | 2.31 | 2.10 |
| EPS Diluted | 2.72 | 2.44 | 1.87 | 2.05 | 1.96 |
| Normalized Diluted EPS | 2.40 | 2.30 | 2.36 | 2.31 | 2.10 |
| Average Basic Shares Outstanding | 868.05M | 808.11M | 747.45M | 722.07M | 721.90M |
| Average Diluted Shares Outstanding | 872.72M | 811.55M | 750.30M | 724.21M | 723.91M |
| Dividend Per Share | 1.32 | 1.29 | 1.26 | 1.23 | 1.20 |
| Payout Ratio | 49.10% | 55.49% | 69.89% | 59.68% | 61.13% |